AUTHOR=Rupp Thomas , Maufrais Claire , Walther Guillaume , Esteve François , Macdonald Jamie Hugo , Bouzat Pierre , Verges Samuel 

TITLE=MEDEX 2015: Prophylactic Effects of Positive Expiratory Pressure in Trekkers at Very High Altitude

JOURNAL=Frontiers in Physiology

VOLUME=12

YEAR=2021

URL=https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2021.710622

DOI=10.3389/fphys.2021.710622

ISSN=1664-042X

ABSTRACT=<p><bold>Purpose:</bold> Positive expiratory pressure (PEP) breathing has been shown to increase arterial oxygenation during acute hypoxic exposure but the underlying mechanisms and consequences on symptoms during prolonged high-altitude exposure remain to be elucidated.</p><p><bold>Methods:</bold> Twenty-four males (41 ± 16 years) were investigated, at sea level and at 5,085 m after 18 days of trekking from 570 m. Participants breathed through a face-mask with PEP = 0 cmH<sub>2</sub>O (PEP<sub>0</sub>, 0–45<sup>th</sup> min) and with PEP = 10 cmH<sub>2</sub>O (PEP<sub>10</sub>, 46–90<sup>th</sup> min). Arterial (SpO<sub>2</sub>), quadriceps and prefrontal (near infrared spectroscopy) oxygenation was measured continuously. Middle cerebral artery blood velocity (MCAv, transcranial Doppler), cardiac function (2D-echocardiography), extravascular lung water accumulation (UsLC, thoracic ultrasound lung comets) and acute mountain sickness (Lake Louise score, LLS) were assessed during PEP<sub>0</sub> and PEP<sub>10</sub>.</p><p><bold>Results:</bold> At 5,085 m with PEP<sub>0</sub>, SpO<sub>2</sub> was 78 ± 4%, UsLC was 8 ± 5 (a.u.) and the LLS was 2.3 ± 1.7 (all <italic>P</italic> &lt; 0.05 versus sea level). At 5,085 m, PEP<sub>10</sub> increased significantly SpO<sub>2</sub> (+9 ± 5%), quadriceps (+2 ± 2%) and prefrontal cortex (+2 ± 2%) oxygenation (<italic>P</italic> &lt; 0.05), and decreased significantly MCAv (−16 ± 14 cm.s<sup>–1</sup>) and cardiac output (−0.7 ± 1.2 L.min<sup>–1</sup>) together with a reduced stroke volume (−9 ± 15 mL, all <italic>P</italic> &lt; 0.05) and no systemic hypotension. PEP<sub>10</sub> decreased slightly the number of UsLC (−1.4 ± 2.7, <italic>P</italic> = 0.04) while the incidence of acute mountain sickness (LLS ≥ 3) fell from 42% with PEP<sub>0</sub> to 25% after PEP<sub>10</sub> (<italic>P</italic> = 0.043).</p><p><bold>Conclusion:</bold> PEP<sub>10</sub> breathing improved arterial and tissue oxygenation and symptoms of acute mountain sickness after trekking to very high altitude, despite reduced cerebral perfusion and cardiac output. Further studies are required to establish whether PEP-breathing prophylactic mechanisms also occur in participants with more severe acute mountain sickness.</p>